Grifols (GIFLF) Cash from Investing Activities (QoQ) (2010 - 2020)

Grifols (GIFLF) Cash from Investing Activities (QoQ) (2010 - 2020) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 71.26%
Mar 31, 2019 -138.22%
Jun 30, 2018 -525.53%
Mar 31, 2018 -95.06%
Jun 30, 2017 -95.53%
Mar 31, 2017 1,746.63%
Dec 31, 2016 84.94%
Dec 31, 2015 -1,648.83%
Sep 30, 2015 -91.38%
Jun 30, 2015 315.70%
Mar 31, 2013 174.25%
Dec 31, 2012 -691.00%
Sep 30, 2012 914.59%
Jun 30, 2012 2,526.63%
Mar 31, 2012 100.14%
Dec 31, 2011 -101.05%
Sep 30, 2011 302.21%
Jun 30, 2011 -9,524.91%
Mar 31, 2011 27.95%
Dec 31, 2010 1.22%